 Novel Vaccination Strategies
ISBN: 978-3-527-30523-0
Hardcover
670 pages
April 2004
US $240.00
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. |
An online version of this product is available through our subscription-based content service. Visit Wiley InterScience now |
PART I.
1. Challenges for the Vaccine Developer, including Correlates of Protection (G. Nossal).
PART II: VACCINATION AND IMMUNE RESPONSE.
2. Shaping Adaptive Immunity against Pathogens: The Contribution of Innate Immune Responses (S. Ehlers & S. Bulfone-Paus).
3. Adjuvant-induced Th2- and Th1 -dominated Immune Responses in Vaccination (J. Brewer & K. Pollock).
4. Memory (A. Ploss & E. Pamer).
5. T-Cell based Vaccines (K. Huster, et al.).
PART III: ADJUVANTS.
6. Microbial Adjuvants (K. Heeg, et al.).
7. Host-derived Adjuvants (N. Hilf, et al.).
8. Microparticles as Vaccine Adjuvants and Delivery Systems (D. O'Hagan & M. Singh).
9. Liposomes and ISCOMs (G. Kersten, et al.).
10. Virosomal Technology and Mucosal Adjuvants (J. Viret, et al.).
PART IV: CLASSICAL AND NOVEL VACCINATION STRATEGIES: A COMPARISON.
11. Classical Bacterial Vaccines (T. Ebensen, et al.).
12. Subunit Vaccines and Toxoids (M. Lattanzi, et al.).
13. Engineering Virus Vectors for Subunit Vaccines (J. Nkolola & T. Hanke).
14. Update on Antiviral DNA Vaccine Research (2000-2003) (D. Franke, et al.).
15. Live Recombinant Bacterial Vaccines (S. Clare & G. Dougan).
16. Mucosal Vaccination (W. Olszewska & P. Openshaw).
17. Passive Vaccination and Antidotes: A Novel Strategy for Generation of Wide-spectrum Protective Antibodies (A. Cassone & L. Polonelli).
18. Plant-based Oral Vaccines (K. Wang, et al.).
19. Virus-like Particles: Combining Innate and Adaptive Immunity for Effective Vaccination (M. Bachmann & G. Jennings).
PART V: VACCINES FOR SPECIFIC TARGETS.
20. Helicobacter Pylori (P. Ruggiero, et al.).
21. Novel Vaccination Strategies against Tuberculosis (S. Kaufmann).
22. Rationale for Malaria Vaccine Development (A. Saul, et al.).
23. Vaccine for Specific Targets: HIV (R. Kay, et al.).
24. Vaccines against Bioterror Agents (K. Elkins, et al.).
PART VI: VACCINES IN THE REAL WORLD: SAFETY, COST EFFICIENCY AND IMPACT OF VACCINATION.
25. Imperfect Vaccines and the Evolution of Pathogen Virulence (P. Ewald).
26. Cost-Effectiveness of Vaccinations (T. Szucs).
27. Immunological Safety of Vaccines: Facts, Hypothesis and Allegations (M. Goldman & P. Lambert).
Index.
